SEC Form 4 · accession 0001185185-17-001915
IGC Pharma, Inc. · IGC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Cherin
Officer — CFO, Treasurer and PAO
Period of report
Aug 25, 2017
Accepted (ET)
Aug 31, 2017 · 7:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326205
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 25, 2017 | D | 10,000 | $0.32 | D | 340,000 | D | |
| Common Stock | Aug 28, 2017 | D | 5,000 | $0.33 | D | 335,000 | D | |
| Common Stock | Aug 29, 2017 | D | 300 | $0.32 | D | 334,700 | D | |
| Common Stock | Aug 30, 2017 | D | 2,000 | $0.32 | D | 332,700 | D | |
| Common Stock | Aug 31, 2017 | D | 1,700 | $0.32 | D | 331,000 | D |
Table II — derivative securities
No Table II lines on this filing.